Look for:

ROCHE HOLDINGS AG GENUSSCHEINE NPV


ISIN:
CH0012032048
WKN:
1203204

2020/09/24 11:21:07
Price
330.50 CHF
Difference -1.14% (-3.80)

General attributes

ISINCH0012032048
SymbolROG
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)271,606 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)330.45 CHF (433)
Ask (Ask size)330.50 CHF (124)
Open330.80 CHF
High333.45 CHF
Low330.40 CHF
Close (prev. day)334.30 CHF
VWAP331.609384 CHF
Volume (pcs)303,833
Trading volume100,753,873.90
Number of trades5,191
Last size6

Futures and Options

Related Futures37
Related Options-

PDF Downloads

Annual report: ROCHE HOLDINGS AG GENUSSCHEINE NPVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2020/09/24 11:21:07
Price
330.50 CHF
Difference -1.14% (-3.80)

General attributes

ISINCH0012032048
SymbolROG
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)271,606 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)330.45 CHF (433)
Ask (Ask size)330.50 CHF (124)
Open330.80 CHF
High333.45 CHF
Low330.40 CHF
Close (prev. day)334.30 CHF
VWAP331.609384 CHF
Volume (pcs)303,833
Trading volume100,753,873.90
Number of trades5,191
Last size6

Performance and Risk

6M1Y3Y
Perf (%)+19.99%+18.17%+34.80%
Perf (abs.)+55.70+51.40+86.30
Beta0.770.870.90
Volatility24.4426.1220.28
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)338.53 CHF (2,538,872)
Ø price 30 days | Ø volume 30 days (pcs.)324.70 CHF (1,678,346)
Ø price 100 days | Ø volume 100 days (pcs.)331.19 CHF (1,699,083)
Ø price 250 days | Ø volume 250 days (pcs.)319.19 CHF (2,159,475)
YTD High | date357.85 CHF (2020/04/28)
YTD Low | date265.75 CHF (2020/03/16)
52 Weeks High | date357.85 CHF (2020/04/28)
52 Weeks Low | date265.75 CHF (2020/03/16)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2019/06/2822:25246.05 EUR0.7546
SIX Swiss Exchange2020/09/2411:21330.50 CHF100.755,191
Munich2019/06/2808:00246.25 EUR0.002
London Stock Exchange European Trade Reporting2019/06/2814:55272.6525 CHF0.3112
Hamburg2019/06/2814:06245.55 EUR0.012
Frankfurt2019/06/2817:41245.60 EUR0.1817
FINRA other OTC Issues2020/09/2321:49357.92 USD5.4933
Duesseldorf2019/06/2808:11245.85 EUR0.002
Berlin2019/06/2818:45245.95 EUR0.0015

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2130&ID_TYPE_IMAGE_LOGO=2

Contact Details

ROCHE HOLDING
Karl Mahler
Grenzacherstraße 124 CH-4070 Basel
Telefon: +41-61-688-1111
Fax: -
E-mail: investor.relations@roche.com

PDF Downloads

Annual report: ROCHE HOLDINGS AG GENUSSCHEINE NPVPDF Download

Company Profile

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

Members of Management Board

Severin SchwanChairman of Managing Board
William AndersonMember of Executive Committee
Thomas SchineckerMember of Executive Committee
Cristina A. WilburMember of Executive Committee
Alan HippeMember of Executive Committee

Board of directors

Paul BulckeMember of the administrative board
Julie BrownMember of the administrative board
Bernard PoussotMember of the administrative board
Anita HauserMember of the administrative board
André HoffmannMember of the administrative board
Richard LiftonMember of the administrative board
Hans CleversMember of the administrative board
- Jo¨rg DuschmaléMember of the administrative board
Severin SchwanMember of the administrative board
Patrick FrostMember of the administrative board
Claudia Süssmuth DyckerhoffMember of the administrative board
Christoph FranzChairman of the administrative boar





Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.